Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics
Go back to Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics| (NASDAQ: AKRO) | Delayed: 54.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.74 | 52 Week High | $ | |||
| Open | $54.74 | 52 Week Low | $ | |||
| Day High | $54.74 | P/E | N/A | |||
| Day Low | $54.74 | EPS | $ | |||
| Volume | 8,001,698 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.74 +0.60 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.14 | 52 Week High | $59.00 | |||
| Open | $46.35 | 52 Week Low | $32.80 | |||
| Day High | $47.17 | P/E | N/A | |||
| Day Low | $46.34 | EPS | $0.00 | |||
| Volume | 10,898,849 | |||||

